These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 684075)

  • 101. 5,7-Dihydroxytryptamine lesions of the amygdala reduce amphetamine- and apomorphine-induced stereotyped behaviour in the rat.
    Carter CJ; Pycock CJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):235-8. PubMed ID: 7190651
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The serotonergic system in the brain and its possible functional connections with other aminergic systems.
    Samanin R; Garattini S
    Life Sci; 1975 Oct; 17(8):1201-9. PubMed ID: 574
    [No Abstract]   [Full Text] [Related]  

  • 103. Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brain.
    Manaker S; Engber TM; Knight PB; Winokur A
    J Neurochem; 1985 Oct; 45(4):1315-8. PubMed ID: 3928818
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat.
    Björklund A; Baumgarten HG; Lachenmayer L; Rosengren E
    Cell Tissue Res; 1975 Aug; 161(2):145-55. PubMed ID: 1175203
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Motor effects of serotonin in the central nervous system.
    Gerson SC; Baldessarini RJ
    Life Sci; 1980 Oct; 27(16):1435-51. PubMed ID: 6160367
    [No Abstract]   [Full Text] [Related]  

  • 106. Effects of 5,6-dihydroxytryptamine on the release, synthesis, and storage of serotonin: studies using rat brain synaptosomes.
    Wolf WA; Bobik A
    J Neurochem; 1988 Feb; 50(2):534-42. PubMed ID: 2447243
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Olfactory projection systems, drugs and behaviour: a review.
    Cairncross KD; Cox B; Forster C; Wren AF
    Psychoneuroendocrinology; 1979 Jul; 4(3):253-72. PubMed ID: 515292
    [No Abstract]   [Full Text] [Related]  

  • 108. 5,7-Dihydroxytryptamine lesions of crayfish serotonin-containing neurons: effect on the lateral giant escape reaction.
    Glanzman DL; Krasne FB
    J Neurosci; 1986 Jun; 6(6):1560-9. PubMed ID: 3711995
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Comparative effects of 5,6-dihydroxytryptamine and its benzo[b]-thiophene analogue on biogenic amines in the rat.
    Donelson AC; Bosin TR; Campaigne E; Rogers RB; Maickel RP
    Biochem Pharmacol; 1979 Nov; 28(22):3339-43. PubMed ID: 526340
    [No Abstract]   [Full Text] [Related]  

  • 110. Effects of acute and chronic administrations of phencyclidine on the levels of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of mouse.
    Nabeshima T; Hiramatsu M; Furukawa H; Kameyama T
    Life Sci; 1985 Mar; 36(10):939-46. PubMed ID: 2579308
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Experimentally induced supersensitivity of neocortical neurons to microiontophoretically administered serotonin.
    Olpe HR; Ortmann R; Fehr B; Waldmeier PC
    Brain Res; 1981 Nov; 224(2):367-74. PubMed ID: 6169411
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Ultrastructure of the regenerating growth cones of catecholamine nerve terminals in rat hypothalamic nuclei after 5,7-dihydroxytryptamine administration.
    Chiba T; Murata Y; Shibata H
    Brain Res; 1982 Apr; 238(2):407-12. PubMed ID: 7093661
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Facilitation of shock-induced fighting following intraventricular 5,7-dihydroxytryptamine and 6-hydroxydopa.
    Kantak KM; Hegstrand LR; Eichelman B
    Psychopharmacology (Berl); 1981; 74(2):157-60. PubMed ID: 6791220
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Biogenic amine levels in the mid-term human fetus.
    Masudi NA; Gilmore DP
    Brain Res; 1983 Mar; 283(1):9-12. PubMed ID: 6187417
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Serotonin depletion modifies the pigeon electroretinogram.
    Porciatti V; Alesci R; Bagnoli P; Signorini G; Raffaelli A
    Doc Ophthalmol; 1989 May; 72(1):93-100. PubMed ID: 2478351
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Inhibition of 5-hydroxytryptamine uptake by tetrahydronorharmane in vivo.
    Rommelspacher H; Strauss S; Cohnitz CH
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):229-33. PubMed ID: 150545
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Intrahypothalamic 5,7-dihydroxytryptamine facilitates feminine sexual behavior and decreases [3H]imipramine binding and 5-HT uptake.
    Luine VN; Frankfurt M; Rainbow TC; Biegon A; Azmitia E
    Brain Res; 1983 Apr; 264(2):344-8. PubMed ID: 6850308
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Structure-activity relationships in compounds analogous to 5,6-dihydroxytryptamine.
    Maickel RP; Bosin TR; Donelson AC; Campaigne E; Rogers RB
    Ann N Y Acad Sci; 1978 Jun; 305():134-46. PubMed ID: 280247
    [No Abstract]   [Full Text] [Related]  

  • 119. Inhibition of 5,7-dihydroxytryptamine-induced supersensitivity to 5-hydroxytryptophan in mice by treatment with cycloheximide.
    Sperk G; Stewart RM; Campbell A; Baldessarini RJ
    Brain Res; 1978 Dec; 159(1):183-94. PubMed ID: 310331
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Oxidation of 5-hydroxytryptamine and 5,7-dihydroxytryptamine. A new oxidation pathway and formation of a novel neurotoxin.
    Wrona MZ; Lemordant D; Lin L; Blank CL; Dryhurst G
    J Med Chem; 1986 Apr; 29(4):499-505. PubMed ID: 3959028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.